Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. markets close in 2 hours 30 minutes

S&P 500
5,845.88
-8.10(-0.14%)
Dow 30
42,929.09
-2.51(-0.01%)
Nasdaq
18,543.62
+3.62(+0.02%)
Russell 2000
2,232.59
-7.12(-0.32%)
Crude Oil
72.36
+1.80(+2.55%)
Gold
2,761.10
+22.20(+0.81%)

Jubilant Pharmova Limited (JUBLPHARMA.NS)

NSE - NSE Real Time Price. Currency in INR

Follow

1,127.35

-56.15

(-4.74%)

At close: 03:30PM IST

Currency in INR

Valuation Measures⁴

Market Cap (intraday)	187.17B
Enterprise Value	214.18B
Trailing P/E	34.00
Forward P/E	N/A
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	2.76
Price/Book (mrq)	3.45
Enterprise Value/Revenue	3.22
Enterprise Value/EBITDA	26.48

Trading Information

Stock Price History

Beta (5Y Monthly)	1.59
52-Week Change ³	230.13%
S&P500 52-Week Change ³	37.82%
52 Week High ³	1,247.15
52 Week Low ³	318.75
50-Day Moving Average ³	1,061.27
200-Day Moving Average ³	764.99

Share Statistics

Avg Vol (3 month) ³	858.27k
Avg Vol (10 day) ³	218.43k
Shares Outstanding ⁵	158.4M
Implied Shares Outstanding ⁶	158.5M
Float ⁸	52.6M
% Held by Insiders ¹	60.77%
% Held by Institutions ¹	19.21%
Shares Short ⁴	N/A
Short Ratio ⁴	N/A
Short % of Float ⁴	N/A
Short % of Shares Outstanding ⁴	N/A
Shares Short (prior month ) ⁴	N/A

Dividends & Splits

Forward Annual Dividend Rate ⁴	5
Forward Annual Dividend Yield ⁴	0.42%
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	0.70
Payout Ratio ⁴	14.36%
Dividend Date ³	N/A
Ex-Dividend Date ⁴	Aug 02, 2024
Last Split Factor ²	21:20
Last Split Date ³	Nov 25, 2010

Financial Highlights

Fiscal Year

Fiscal Year Ends	Mar 31, 2024
Most Recent Quarter (mrq)	Jun 30, 2024

Profitability

Profit Margin	8.07%
Operating Margin (ttm)	9.29%

Management Effectiveness

Return on Assets (ttm)	N/A
Return on Equity (ttm)	N/A

Income Statement

Revenue (ttm)	68.48B
Revenue Per Share (ttm)	433.64
Quarterly Revenue Growth (yoy)	9.10%
Gross Profit (ttm)	N/A
EBITDA	10.09B
Net Income Avi to Common (ttm)	5.53B
Diluted EPS (ttm)	34.79
Quarterly Earnings Growth (yoy)	7,432.80%

Balance Sheet

Total Cash (mrq)	9.57B
Total Cash Per Share (mrq)	60.41
Total Debt (mrq)	36.64B
Total Debt/Equity (mrq)	67.59%
Current Ratio (mrq)	N/A
Book Value Per Share (mrq)	342.17

Cash Flow Statement

Operating Cash Flow (ttm)	N/A
Levered Free Cash Flow (ttm)	N/A